Drug intelligence / Profile preview

DBI UC-MSC

Development stage
Unknown
Lead developer
Daewoong Pharmaceutical
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

DBI UC-MSC is an allogeneic cell therapy consisting of mesenchymal stem cells (MSCs) derived from human umbilical cord tissue. Developed by Daewoong Biologics Indonesia, a subsidiary of Daewoong Pharmaceutical, the therapy is primarily being investigated for the treatment of frailty in elderly patients. The therapy leverages the immunomodulatory and regenerative properties of mesenchymal stem cells to address systemic inflammation and tissue degradation associated with aging and frailty. It is administered via intravenous infusion. In August 2024, the developer received certification from Indonesia's BPOM for its manufacturing facility in Cikarang, which is the first foreign-owned stem cell facility in Indonesia to receive Good Manufacturing Practice (GMP) certification.

Other names
Daewoong Biologics Indonesia Umbilical Cord-derived Mesenchymal Stem CellAllogeneic Umbilical Cord-derived Mesenchymal Stem Cells

Beyond the preview

Go deeper on DBI UC-MSC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DBI UC-MSC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call